Down's Syndrome screening: Confusion or consensus?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 6, 2004, Pages 517-518

  Goldberg, James D ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORION VILLUS; DIAGNOSTIC TEST; DOWN SYNDROME; EDITORIAL; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETICS; HEALTH PRACTITIONER; HUMAN; KARYOTYPING; MATERNAL AGE; PRIORITY JOURNAL; SCREENING; SECOND TRIMESTER PREGNANCY; ULTRASOUND; URINE;

BIOLOGICAL MARKERS; CONSENSUS; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 2942612101     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00192.x     Document Type: Editorial

References (5)

1. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies. Ultrasound Obstet Gynecol 2002;20(3): 219-225.
2. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352(9125):343-346.
3. Wald NJ, Rodeck C, Hackshaw AK. SURUSS in perspective. Br J Obstet Gynaecol 2004.
4. Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I: Technical considerations. Genet Med 2000;2(6):356-361.
5. Malone FD, Wald NJ, Canick JA, et al. First and second trimester evaluation of risk (faster) trial: principal results of the NICHD multicenter down syndrome screening study. Am J Obstet Gynecol 2004; 189(6):s56.